Nirsevimab-a breakthrough in respiratory syncytial virus bronchiolitis.

Lancet Child Adolesc Health

Department of General Pediatrics, Pediatric Infectious Disease and Internal Medicine, Robert Debré University Hospital, APHP, Paris, France; Infection, Antimicrobials, Modelling, Evolution Research Unit, INSERM UMR 1137, Paris Cité University, 75018 Paris, France; Groupe de Pathologie Infectieuse Pédiatrique, Nice, France.

Published: October 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-4642(24)00228-1DOI Listing

Publication Analysis

Top Keywords

nirsevimab-a breakthrough
4
breakthrough respiratory
4
respiratory syncytial
4
syncytial virus
4
virus bronchiolitis
4
nirsevimab-a
1
respiratory
1
syncytial
1
virus
1
bronchiolitis
1

Similar Publications

Nirsevimab-a breakthrough in respiratory syncytial virus bronchiolitis.

Lancet Child Adolesc Health

October 2024

Department of General Pediatrics, Pediatric Infectious Disease and Internal Medicine, Robert Debré University Hospital, APHP, Paris, France; Infection, Antimicrobials, Modelling, Evolution Research Unit, INSERM UMR 1137, Paris Cité University, 75018 Paris, France; Groupe de Pathologie Infectieuse Pédiatrique, Nice, France.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!